Active surveillance

Active surveillance has been studied in 10 papers since 2017: 6 observational studies in people, 4 reviews; 3 in the past year. The newest paper, Oct 18, 2026: “Key performance indicators for organized risk stratified prostate cancer screening in Europe: first results from the PRAISE-U and EUCanScreen pilots and the Swedish organised prostate cancer testing programme”.

Intervention

10 papers study it2 findingsUpdated

1 new paper in 30 daysSee all 10

  • 1 lab in 1 country
  • Humans6

What did studies of Active surveillance find?

1

Studies of Active surveillance measured 1 outcome; the most studied are harm (1 study).

Harm

downin humans1

1 study
  1. Active surveillance decreases harm in humans.

    “adopting conservative management strategies such as active surveillance to minimize harm.”

    Reviewmanagement of prostate cancer

    Overdiagnosis and Overtreatment in Prostate Cancer

    Diseases (Basel, Switzerland)

What is Active surveillance linked with?

1

Studies link Active surveillance with 1 measure, most often conversion to active treatment (1 study).

Conversion to active treatment

downin humans1

1 study
  1. Active surveillance is associated with conversion to active treatment in humans (4-26%).

    “There was a low (4-26%) rate of conversion to active treatment for active surveillance in the identified studies over a follow-up interval of up to 91.5 mo.”

    Reviewsmall renal massesup to 91.5 mon = 36,495

    Active Surveillance in Small Renal Masses in the Elderly: A Literature Review

    European urology focus

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 2Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 13 papers in 12 months